K L Gratz1, M T Tull1, R Levy2. 1. Department of Psychiatry and Human Behavior,University of Mississippi Medical Center,Jackson, MS,USA. 2. T. Denny Sanford School of Social and Family Dynamics,Arizona State University,Tempe, AZ,USA.
Abstract
BACKGROUND: Despite the clinical importance of deliberate self-harm (DSH; also referred to as non-suicidal self-injury) within borderline personality disorder (BPD), empirically supported treatments for this behavior among individuals with BPD are difficult to implement in many clinical settings. To address this limitation, a 14-week, adjunctive emotion regulation group therapy (ERGT) for DSH among women with BPD was developed. The current study examined the efficacy of this ERGT in a randomized controlled trial (RCT) and the durability of treatment gains over a 9-month uncontrolled follow-up period. METHOD:Female out-patients with BPD and recent recurrent DSH were randomly assigned to receive this ERGT in addition to their ongoing out-patient therapy immediately (n = 31) or after 14 weeks (n = 30). Measures of DSH and other self-destructive behaviors, psychiatric symptoms, adaptive functioning and the proposed mechanisms of change (emotion dysregulation/avoidance) were administered pre- and post-treatment or -waitlist (to assess treatment efficacy), and 3 and 9 months post-treatment (to assess durability of treatment gains). RESULTS: Intent-to-treat (ITT) analyses (n = 61) revealed significant effects of this ERGT on DSH and other self-destructive behaviors, emotion dysregulation, BPD symptoms, depression and stress symptoms, and quality of life. Analyses of all participants who began ERGT (across treatment and waitlist conditions; n = 51) revealed significant improvements from pre- to post-treatment on all outcomes, additional significant improvements from post-treatment to 9-month follow-up for DSH, emotion dysregulation/avoidance, BPD symptoms and quality of life, and no significant changes from post-treatment to 9-month follow-up on the other measures. CONCLUSIONS: The results support the efficacy of this ERGT and the durability of treatment gains.
RCT Entities:
BACKGROUND: Despite the clinical importance of deliberate self-harm (DSH; also referred to as non-suicidal self-injury) within borderline personality disorder (BPD), empirically supported treatments for this behavior among individuals with BPD are difficult to implement in many clinical settings. To address this limitation, a 14-week, adjunctive emotion regulation group therapy (ERGT) for DSH among women with BPD was developed. The current study examined the efficacy of this ERGT in a randomized controlled trial (RCT) and the durability of treatment gains over a 9-month uncontrolled follow-up period. METHOD: Female out-patients with BPD and recent recurrent DSH were randomly assigned to receive this ERGT in addition to their ongoing out-patient therapy immediately (n = 31) or after 14 weeks (n = 30). Measures of DSH and other self-destructive behaviors, psychiatric symptoms, adaptive functioning and the proposed mechanisms of change (emotion dysregulation/avoidance) were administered pre- and post-treatment or -waitlist (to assess treatment efficacy), and 3 and 9 months post-treatment (to assess durability of treatment gains). RESULTS: Intent-to-treat (ITT) analyses (n = 61) revealed significant effects of this ERGT on DSH and other self-destructive behaviors, emotion dysregulation, BPD symptoms, depression and stress symptoms, and quality of life. Analyses of all participants who began ERGT (across treatment and waitlist conditions; n = 51) revealed significant improvements from pre- to post-treatment on all outcomes, additional significant improvements from post-treatment to 9-month follow-up for DSH, emotion dysregulation/avoidance, BPD symptoms and quality of life, and no significant changes from post-treatment to 9-month follow-up on the other measures. CONCLUSIONS: The results support the efficacy of this ERGT and the durability of treatment gains.
Authors: Michael J McDermott; Joshua C Fulwiler; Todd A Smitherman; Kim L Gratz; Kevin M Connolly; Matthew T Tull Journal: J Behav Med Date: 2015-11-26
Authors: Nicole H Weiss; Matthew T Tull; Tami P Sullivan; Katherine L Dixon-Gordon; Kim L Gratz Journal: Drug Alcohol Depend Date: 2015-08-02 Impact factor: 4.492
Authors: Nathan A Kimbrel; Bryann B DeBeer; Eric C Meyer; Suzy B Gulliver; Sandra B Morissette Journal: Psychiatry Res Date: 2016-06-28 Impact factor: 3.222
Authors: Anne C Knorr; Matthew T Tull; Michael D Anestis; Katherine L Dixon-Gordon; Mary F Bennett; Kim L Gratz Journal: Arch Suicide Res Date: 2016-03-08